Exane Derivatives’s Philip Morris PM Stock Holding History

Exane Derivatives’s Portfolio PM Stock Details PM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-87	Closed	-$177K	–	941
2021 Q3	$177K	Hold	87	–	–	0.04%	424
2021 Q2	$207K	Hold	87	–	–	0.05%	381
2021 Q1	$126K	Buy	+87	New	+$7.39K	0.04%	383
2020 Q4	–	Sell	-87	Closed	-$54.7K	–	860
2020 Q3	$54.7K	Buy	+87	New	+$6.71K	0.02%	371
2017 Q4	–	Sell	-250	Closed	-$308K	–	629
2017 Q3	$308K	Hold	250	–	–	0.06%	168
2017 Q2	$472K	Buy	+250	New	+$29K	0.1%	141
2017 Q1	–	Sell	-550	Closed	-$67.5K	–	644
2016 Q4	$67.5K	Hold	550	–	–	0.01%	272
2016 Q3	$195K	Buy	+550	New	+$55.1K	0.03%	207
2016 Q2	–	Sell	-300	Closed	-$113K	–	610
2016 Q1	$113K	Hold	300	–	–	0.02%	231
2015 Q4	$39K	Sell	300 -250	-45%	-$21.7K	0.01%	269
2015 Q3	$61.5K	Buy	550 +300	+120%	+$24.7K	0.01%	253
2015 Q2	$62K	Hold	250	–	–	0.01%	272
2015 Q1	$30.9K	Hold	250	–	–	﹤0.01%	343
2014 Q4	$113K	Buy	+250	New	+$21.5K	0.02%	273

Other funds holding PM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exane Derivatives's PM Position: Q2 2022 in Review

Exane Derivatives reduced its Philip Morris (PM) stake by 43% in Q2 2022, selling an estimated $1.02K and leaving 13 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Exane Derivatives first reported a position in PM in Q4 2014 and has held it in 28 quarters since. The position peaked at $6.45M in Q2 2018. 1,980 funds tracked by Wall St. Rank hold PM as of Q2 2022.

Exane Derivatives held 13 shares of Philip Morris worth $1.28K as of Q2 2022.
Exane Derivatives sold 10 Philip Morris shares in Q2 2022, an estimated $1.02K.
Philip Morris made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #479 holding.
Exane Derivatives first reported a position in Philip Morris in Q4 2014 and has held it in 28 quarters since.
Exane Derivatives's Philip Morris position peaked at $6.45M in Q2 2018.
1,980 funds tracked by Wall St. Rank held Philip Morris as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.